PharmaTher Holdings Ltd. (OTCMKTS:PHRRF – Get Free Report) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totaling 9,702 shares, an increase of 68.1% from the September 30th total of 5,771 shares. Based on an average daily volume of 128,315 shares, the days-to-cover ratio is currently 0.1 days.
PharmaTher Stock Performance
OTCMKTS PHRRF opened at $0.04 on Monday. The firm’s fifty day moving average is $0.04 and its two-hundred day moving average is $0.05. PharmaTher has a one year low of $0.03 and a one year high of $0.12.
PharmaTher Company Profile
PharmaTher Inc is a specialty pharmaceutical company focused on the development and commercialization of repurposed and reformulated medicines for neurological and psychiatric conditions. The company’s strategy centers on advancing existing drug compounds through new formulations, delivery methods, or therapeutic applications.
PharmaTher has historically focused on ketamine-based treatments, including programs intended to address conditions such as depression and other mental-health disorders.
Further Reading
- Five stocks we like better than PharmaTher
- STMicroelectronics Could Reach New Highs—Here’s What Needs to Happen
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
